Related Experiment Video
Updated: Jun 20, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy
Carla Spazzolini1, Jamie Mullally, Arthur J Moss
1Section of Cardiology and Department of Cardiology and Molecular Cardiology Laboratory, Fondazione Policinico S. Matteo IRCCS and the University of Pavia, Pavia, Italy.
Insights
Infants with long QT syndrome (LQTS) experiencing aborted cardiac arrest (ACA) face a very high risk of future cardiac events. Beta-blockers may not effectively prevent these events in this high-risk group.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Genetics
Background:
- Clinical implications of cardiac events in infancy due to Long QT Syndrome (LQTS) remain understudied.
- Previous research has not focused on the long-term prognosis of LQTS patients experiencing cardiac events within the first year of life.
Purpose of the Study:
- To evaluate the clinical and prognostic significance of LQTS-related cardiac events occurring in infancy.
- To identify risk factors for cardiac events in the first year of life and assess long-term outcomes.
Main Methods:
- Analysis of data from the International LQTS Registry, including 3,323 patients with corrected QT interval (QTc) ≥450 ms.
- Categorization of patients into groups: sudden cardiac death (SCD), aborted cardiac arrest (ACA), syncope, and asymptomatic.
- Identification of risk factors for cardiac events in 212 patients with electrocardiograms in the first year of life.
Main Results:
- Risk factors for cardiac events in infancy included QTc ≥500 ms, heart rate ≤100 bpm, and female sex.
- ACA in the first year of life significantly increased the risk of ACA or SCD between ages 1-10 years (HR 23.4, p < 0.01).
- Beta-blocker therapy showed a reduction in ACA/SCD only for those with prior syncope, not for infants surviving ACA.
Conclusions:
- Infants with LQTS experiencing ACA are at extremely high risk for subsequent life-threatening cardiac events.
- Beta-blocker efficacy in preventing fatal or near-fatal events in this specific high-risk infant subset may be limited.
- Early identification and risk stratification are crucial for managing LQTS in infancy.
Objectives:
This study was designed to evaluate the clinical and prognostic aspects of long QT syndrome (LQTS)-related cardiac events that occur in the first year of life (infancy).
Background:
The clinical implications for patients with long QT syndrome who experience cardiac events in infancy have not been studied previously.
Methods:
The study population of 3,323 patients with QT interval corrected for heart rate (QTc) > or =450 ms enrolled in the International LQTS Registry involved 20 patients with sudden cardiac death (SCD), 16 patients with aborted cardiac arrest (ACA), 34 patients with syncope, and 3,253 patients who were asymptomatic during the first year of life.
Results:
The risk factors for a cardiac event among 212 patients who had an electrocardiogram recorded in the first year of life included QTc > or =500 ms, heart rate < or =100 beats/min, and female sex. An ACA before age 1 year was associated with a hazard ratio of 23.4 (p < 0.01) for ACA or SCD during ages 1 to 10 years. During the 10-year follow-up after infancy, beta-blocker therapy was associated with a significant reduction in ACA/SCD only in those with a syncopal episode within 2 years before ACA/SCD but not for those who survived ACA in infancy.
Conclusions:
Patients with LQTS who experience ACA during the first year of life are at very high risk for subsequent ACA or death during their next 10 years of life, and beta-blockers might not be effective in preventing fatal or near-fatal cardiac events in this small but high-risk subset.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mechanism of Cardiac Arrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
